Piperacillin - Tazobactam

Restricted
C difficile risk
Medium
Oral Bioavailability
N/A
Cost
$

Spectrum Of Activity

Dosing

PNA-days 0 - 28PNA-days 29+ 50-100 mg/kg/dose IV q12h Dosing is based on the piperacillin component50-100 mg/kg/dose IV q8h Dosing is based on the piperacillin component

PNA-days 0 - 14PNA-days 15+ 50-100 mg/kg/dose IV q12h Dosing is based on the piperacillin component50-100 mg/kg/dose IV q8h Dosing is based on the piperacillin component

0 - 7 8+ 50-100 mg/kg/dose IV q12h Dosing is based on the piperacillin component50-100 mg/kg/dose IV q8h Dosing is based on the piperacillin component

General Information

Adults:

  • Complicated intra-abdominal infection in patient with recent antibiotic exposure or recent abdominal surgery

  • Hemodialysis patients requiring antipseudomonal therapy

  • Prophylaxis for hepato-pancreato-biliary procedures

  • I.D. authorization

Pediatrics:

  • I.D. authorization required
Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.